Get access

Molecular diagnostic strategies: a role in the practice of dermatology

Authors

  • Zendee Elaba MD,

    1. Department of Pathology, Hartford Hospital, Hartford
    2. Department of Dermatology, University of Connecticut Health Center, Farmington, CT, USA
    Search for more papers by this author
  • Amanda Phelps BA,

    1. Department of Pathology, Hartford Hospital, Hartford
    2. Department of Dermatology, University of Connecticut Health Center, Farmington, CT, USA
    Search for more papers by this author
  • Michael J. Murphy MD

    1. Department of Pathology, Hartford Hospital, Hartford
    2. Department of Dermatology, University of Connecticut Health Center, Farmington, CT, USA
    Search for more papers by this author

  • Funding Sources: None.

  • Conflict of Interest: None declared.

Dr Michael J. Murphy, md
Department of Dermatology
University of Connecticut Health Center
21 South Road, Farmington
CT 06030, USA
E-mail: drmichaelmurphy@netscape.net

Abstract

Molecular diagnostic strategies are gaining wider acceptance and use in dermatology and dermatopathology as more practitioners in this field develop an understanding of the principles and applications of genomic technologies. Molecular testing is facilitating more accurate diagnosis, staging, and prognostication, in addition to guiding the selection of appropriate treatment, monitoring of therapy, and identification of novel therapeutic targets, for a wide variety of skin diseases.

Ancillary